Comparative effectiveness of <scp>GLP</scp> ‐1 receptor agonists, <scp>SGLT2</scp> inhibitors and <scp>DPP</scp> ‐4 inhibitors on liver outcomes in metabolic dysfunction‐associated steatotic liver disease: A retrospective cohort study
In this large real-world study, we found no clear or consistent differences in liver-related outcomes across GLP-1RA, SGLT2i, and DPP-4i users over a 2-year period.
Authors
- Michael Kim (ORCID: https://orcid.org/0000-0003-0087-0199)
- Ebere Okpara (ORCID: https://orcid.org/0000-0003-0766-3993)
- Jyotirmoy Sarker (ORCID: https://orcid.org/0000-0002-2528-5458)
- Kibum Kim (ORCID: https://orcid.org/0000-0002-7381-019X)
- Bertha De Los Santos
Institutions
- Illinois College (US)
- University of Illinois Chicago (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1111/dom.70505
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 31.52